Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

Bolt Biotherapeutics, Inc. BOLT

Full chart Compare
Set alert

Price alert · BOLT

All alert types
6.57 USD +0.33 (+5.29%)

At closeNov 4, 2026, 4:00 AM EST

7.18 +0.61 +9.21%

Pre-market · Nov 4, 4:00 AM ET

6.11 Day range 6.74
3.10 52-week range 7.78
YTD
+20.11%
1 year
+30.36%

Financial health

Altman Z-Score

-18.10 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

2 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

FMP rating

C2 / 5 overall

  • DCF 1
  • Return on Equity 1
  • Return on Assets 1
  • Debt / Equity 1
  • P/E 1
  • P/B 5

Valuation

P/E -0.3×
FY 2018: -108×FY 2019: -171×FY 2020: -323×FY 2021: -35.1×FY 2022: -11.3×FY 2023: -12.2×FY 2024: -6.5×FY 2025: -0.3×
FY 2018 5y median -11.3× FY 2025
P/S 1.3×
FY 2018: 0.0×FY 2019: 1198×FY 2020: 5044×FY 2021: 145×FY 2022: 8.5×FY 2023: 5.4×FY 2024: 2.7×FY 2025: 1.3×
FY 2018 5y median 5.4× FY 2025
P/B 0.4×
FY 2018: -3.9×FY 2019: -5.6×FY 2020: -11.1×FY 2021: 0.7×FY 2022: 0.3×FY 2023: 0.4×FY 2024: 0.4×FY 2025: 0.4×
FY 2018 5y median 0.4× FY 2025
P/FCF -0.3×
FY 2018: -6.1×FY 2019: -9.6×FY 2020: -23.0×FY 2021: -3.1×FY 2022: -0.6×FY 2023: -0.6×FY 2024: -0.3×FY 2025: -0.3×
FY 2018 5y median -0.6× FY 2025
EV/EBITDA -0.7×
FY 2018: -4.3×FY 2019: -7.6×FY 2020: -24.1×FY 2021: -1.9×FY 2022: -0.7×FY 2023: -0.8×FY 2024: -0.6×FY 2025: -0.7×
FY 2018 5y median -0.7× FY 2025
EV/Sales 2.8×
FY 2018: 0.0×FY 2019: 1083×FY 2020: 5067×FY 2021: 143×FY 2022: 10.8×FY 2023: 6.6×FY 2024: 5.0×FY 2025: 2.8×
FY 2018 5y median 6.6× FY 2025
FCF Yield -390.3%
FY 2018: -16.3%FY 2019: -10.4%FY 2020: -4.3%FY 2021: -32.4%FY 2022: -161.5%FY 2023: -164.6%FY 2024: -300.3%FY 2025: -390.3%
FY 2018 5y median -164.6% FY 2025

Profitability

Gross Margin 80.6%
FY 2018: 0.0%FY 2019: 100.0%FY 2020: -17370.6%FY 2021: -5904.4%FY 2022: -1176.4%FY 2023: -681.4%FY 2024: 100.0%FY 2025: 80.6%
FY 2018 5y median -681.4% FY 2025
Operating Margin -450.1%
FY 2018: 0.0%FY 2019: -14404.2%FY 2020: -21290.9%FY 2021: -7364.1%FY 2022: -1576.6%FY 2023: -967.4%FY 2024: -949.9%FY 2025: -450.1%
FY 2018 5y median -967.4% FY 2025
Net Margin -433.7%
FY 2018: 0.0%FY 2019: -14180.0%FY 2020: -26289.2%FY 2021: -7824.7%FY 2022: -1537.8%FY 2023: -878.6%FY 2024: -820.8%FY 2025: -433.7%
FY 2018 5y median -878.6% FY 2025
ROE -125.9%
FY 2018: 72.7%FY 2019: 66.5%FY 2020: 57.9%FY 2021: -39.4%FY 2022: -51.4%FY 2023: -61.4%FY 2024: -110.4%FY 2025: -125.9%
FY 2018 5y median -61.4% FY 2025
ROIC -67.7%
FY 2018: -87.7%FY 2019: -72.2%FY 2020: -133.7%FY 2021: -32.1%FY 2022: -43.6%FY 2023: -53.6%FY 2024: -84.9%FY 2025: -67.7%
FY 2018 5y median -53.6% FY 2025
ROA -58.8%
FY 2018: -72.5%FY 2019: -62.9%FY 2020: -130.5%FY 2021: -32.0%FY 2022: -38.7%FY 2023: -43.3%FY 2024: -63.4%FY 2025: -58.8%
FY 2018 5y median -43.3% FY 2025

Growth (YoY)

Revenue 0.1%
FY 2018: 0.0%FY 2019: 0.0%FY 2020: 7.4%FY 2021: 445.5%FY 2022: 354.7%FY 2023: 37.5%FY 2024: -2.4%FY 2025: 0.1%
FY 2018 FY 2025
Operating Income 52.6%
FY 2018: 0.0%FY 2019: -166.3%FY 2020: -58.8%FY 2021: -88.7%FY 2022: 2.7%FY 2023: 15.6%FY 2024: 4.1%FY 2025: 52.6%
FY 2018 FY 2025
EPS (diluted) -981.8%
FY 2018: 0.0%FY 2019: 37.1%FY 2020: 46.9%FY 2021: -40.2%FY 2022: 17.6%FY 2023: 20.4%FY 2024: 9.8%FY 2025: -981.8%
FY 2018 FY 2025
Free Cash Flow 34.9%
FY 2018: 0.0%FY 2019: -164.2%FY 2020: -88.3%FY 2021: -17.5%FY 2022: -32.1%FY 2023: 11.1%FY 2024: 12.0%FY 2025: 34.9%
FY 2018 FY 2025

Financial Health

Current Ratio 3.6×
FY 2018: 5.1×FY 2019: 4.1×FY 2020: 2.3×FY 2021: 8.9×FY 2022: 7.5×FY 2023: 5.2×FY 2024: 3.2×FY 2025: 3.6×
FY 2018 5y median 5.2× FY 2025
Quick Ratio 3.6×
FY 2018: 5.1×FY 2019: 4.1×FY 2020: 2.3×FY 2021: 8.9×FY 2022: 7.5×FY 2023: 5.2×FY 2024: 3.2×FY 2025: 3.6×
FY 2018 5y median 5.2× FY 2025
Debt / Equity 0.9×
FY 2018: -0.0×FY 2019: -0.2×FY 2020: -0.1×FY 2021: 0.1×FY 2022: 0.1×FY 2023: 0.2×FY 2024: 0.4×FY 2025: 0.9×
FY 2018 5y median 0.2× FY 2025
Net Debt / EBITDA -0.4×
FY 2018: 1.2×FY 2019: 0.8×FY 2020: -0.1×FY 2021: 0.0×FY 2022: -0.2×FY 2023: -0.1×FY 2024: -0.3×FY 2025: -0.4×
FY 2018 5y median -0.2× FY 2025
Interest Coverage 0.0×
FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2018 5y median 0.0× FY 2025

Dividends

Dividend Yield 0.0%
FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2018 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2018 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31